Market Overview



Rigrodsky & Long, P.A.:

  • Do you own shares of Nutraceutical International Corporation
  • Did you purchase any of your shares prior to May 22, 2017?
  • Do you think the proposed buyout is fair?
  • Do you want to discuss your rights?

& Long, P.A.
announces that it is investigating potential legal
claims against the board of directors of Nutraceutical International
Corporation ("Nutraceutical" or the "Company") (NASDAQ GS: NUTR)
regarding possible breaches of fiduciary duties and other violations of
law related to the Company's entry into an agreement to be acquired by
an affiliate of HGGC, LLC ("HGGC") in a transaction valued at
approximately $446 million. Under the terms of the agreement,
shareholders of Nutraceutical will receive $41.80 in cash for each share
of Nutraceutical common stock.

Click here to learn more:

If you own common stock of Nutraceutical and purchased any shares before
May 22, 2017, if you would like to learn more about this investigation,
or if you have any questions concerning this announcement or your rights
or interests, please contact Seth D. Rigrodsky or Gina M. Serra at
Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE
19803, by telephone at (888) 969-4242; by e-mail at;
or at:

& Long, P.A.
, with offices in Wilmington, Delaware and Garden
City, New York, regularly prosecutes securities
fraud, shareholder corporate, and shareholder derivative litigation

on behalf of shareholders in state and federal courts throughout the
United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at